FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
9 letters match. Newest first.
-
BiologicsTides Medical LLC
FDA warns Tides Medical over APLICOR 3D wound device sold without approval, exemption, or required FDA notice.
High risk -
DevicesZIIP, Inc.
FDA warns ZIIP over quality-system violations and unapproved marketing of HALO 2.0, DOT, and gels.
High risk -
DevicesAseptiKits, LLC
AseptiKits marketed unapproved sterile-preparation device kits without FDA clearance or approval, FDA says.
High risk -
BiologicsEstar Technologies Ltd
FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.
High risk -
Biologics4U Health
FDA says 4U Health sells an unapproved HIV dried blood spot self-collection kit, making it adulterated and misbranded.
High risk -
BiologicsGenovate
FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.
High risk -
DevicesSeniorLife Technologies, Inc.
FDA warns SeniorLife Technologies that its SeniorLife.AI app is unapproved and misbranded, with quality-system and reporting failures.
High risk -
BiologicsO3UV, LLC
FDA warns O3UV that its Champion and EBOO ozone/UV blood devices are unapproved, misbranded, and made without required quality controls.
High risk -
DevicesWHOOP, Inc.
FDA warns WHOOP it markets Blood Pressure Insights without device clearance or approval.
High risk